DeciBio
Rebecca Burnham, PhD, is currently working as a Product Manager at DeciBio, bringing their experience as an Associate Product Manager from IsoPlexis. Previously, Rebecca served as a Biotechnology Consultant at Emory University after completing their PhD in Molecular and Systems Pharmacology. Throughout their career, Rebecca has also held roles as a Project Manager, Biology Laboratory Instructor, and Research Student in various organizations such as Emory University Sleep Consortium, Emory University, Joslin Diabetes Center, Camp Sewataro, and Sudbury Extended Day. Rebecca's educational background includes a Bachelor of Arts in Neuroscience from Hamilton College and a Doctor of Philosophy in Biological and Biomedical Sciences from Emory University.
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.